. | i-IGT1 vs. no GDM (95% CI) . | i-IFG vs. no GDM (95% CI) . | i-IGT2 vs. no GDM (95% CI) . | IFG+IGT vs. no GDM (95% CI) . |
---|---|---|---|---|
LGA | 1.25 (0.87–1.77) | 2.00 (1.62–2.45) | 1.51 (0.74–3.05) | 2.32 (1.72–3.13) |
Primary cesarean section | 1.03 (0.77–1.38) | 1.16 (0.95–1.41) | 1.39 (0.78–2.46) | 1.36 (1.00–1.85) |
Preterm delivery | 1.90 (1.38–2.63) | 1.50 (1.16–1.95) | 2.85 (1.59–5.10) | 1.33 (0.87–2.03) |
Shoulder dystocia/birth injury | 1.31 (0.80–2.16) | 1.45 (1.05–2.00) | 1.72 (0.68–4.35) | 1.87 (1.18–2.96) |
Gestational hypertension | 1.49 (1.03–2.16) | 1.29 (1.01–1.66) | 2.33 (1.20–4.51) | 2.01 (1.42–2.84) |
Hyperbilirubinemia | 1.33 (1.02–1.74) | 1.04 (0.85–1.27) | 1.56 (0.92–2.65) | 0.96 (0.69–1.33) |
. | i-IGT1 vs. no GDM (95% CI) . | i-IFG vs. no GDM (95% CI) . | i-IGT2 vs. no GDM (95% CI) . | IFG+IGT vs. no GDM (95% CI) . |
---|---|---|---|---|
LGA | 1.25 (0.87–1.77) | 2.00 (1.62–2.45) | 1.51 (0.74–3.05) | 2.32 (1.72–3.13) |
Primary cesarean section | 1.03 (0.77–1.38) | 1.16 (0.95–1.41) | 1.39 (0.78–2.46) | 1.36 (1.00–1.85) |
Preterm delivery | 1.90 (1.38–2.63) | 1.50 (1.16–1.95) | 2.85 (1.59–5.10) | 1.33 (0.87–2.03) |
Shoulder dystocia/birth injury | 1.31 (0.80–2.16) | 1.45 (1.05–2.00) | 1.72 (0.68–4.35) | 1.87 (1.18–2.96) |
Gestational hypertension | 1.49 (1.03–2.16) | 1.29 (1.01–1.66) | 2.33 (1.20–4.51) | 2.01 (1.42–2.84) |
Hyperbilirubinemia | 1.33 (1.02–1.74) | 1.04 (0.85–1.27) | 1.56 (0.92–2.65) | 0.96 (0.69–1.33) |
*Odds ratios are adjusted for maternal age, race/ethnicity, parity, prepregnancy BMI, gestational weight gain, infant sex, and gestational age at OGTT.